Slipped Capital Femoral Epiphysis, commonly known as SCFE, is a condition that affects the hip joint in young adolescents. It occurs when the growth plate of the femur (thigh bone) slips out of place from the ball at the top of the femur. Although it is not a common ailment, early diagnosis and treatment are crucial to prevent long-term complications such as osteoarthritis and avascular necrosis. In this blog post, we will delve into everything medical professionals should know about SCFE - from its causes and symptoms to its treatment options and long-term effects. So strap on your seatbelts and let's dive deep into understanding SCFE!
Slipped Capital Femoral Epiphysis (SCFE) is a condition that requires immediate medical attention. The main goal of treatment for SCFE is to stabilize the slipped epiphysis and prevent further slippage.
Surgery is typically required for most cases of SCFE, which involves placing screws or pins in the affected hip joint to hold it in place. This procedure aims to reduce pain and restore normal movement in the hip joint.
After surgery, patients will need to undergo physical therapy sessions to help them regain strength and flexibility in their hip muscles. Physical therapy also helps improve balance and mobility while avoiding any unnecessary strain on the affected area.
Slipped Capital Femoral Epiphysis (SCFE) is a condition that affects the hip joint of children and teenagers. While it can be treated, there are some long-term effects that patients need to take note of.
One long-term effect of SCFE is arthritis. Due to the abnormal growth and development of the hip joint during SCFE, patients may experience pain and stiffness in their hips as they grow older. This can eventually lead to difficulty with mobility and daily activities.
In severe cases, avascular necrosis (AVN) can occur which means loss of blood supply to bone tissue leading to its death. If AVN does develop, it could require surgical intervention such as a total joint replacement procedure.
Another potential consequence is leg length discrepancy where one leg appears shorter than the other due to differences in growth rates between both legs after treatment or surgery for SCFE.
Slipped capital femoral epiphysis is a serious condition that can cause long-term effects if not treated promptly. Medical professionals should be aware of the signs and symptoms of SCFE in order to diagnose it early and recommend appropriate treatment options.
Early diagnosis and intervention can help prevent further complications such as avascular necrosis or degenerative arthritis. Treatment options include surgical intervention, physical therapy, and medication management.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation